Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07749872

KAP TB in Senior Management Officials of Companies With Increased Silica Exposure

Conditions: TB - Tuberculosis, Silicosis, Occupational Exposure, Occupational Health

Sex: All
Healthy volunteers: Yes
Enrollment: 118
Sponsor: Centre for Infectious Disease Research in Zambia

Location: CIDRZ Lusaka Lusaka Province

Summary

The study was designed as a descriptive cross-sectional survey conducted between February and October 2022. Senior management officials were targeted because of their role in workplace policy and oversight. The sample was drawn from companies registered under the Zambia Chamber of Commerce and Industry (ZACCI), focusing on those with known silica dust exposure. Each company was asked to provide one or two senior officials to participate. A total of 118 individuals completed the survey. Data collection was carried out using a self-administered electronic questionnaire developed in line with WHO recommendations for TB KAP surveys. The questionnaire contained 28 mandatory closed-ended questions: 7 on knowledge, 8 on attitudes, and 13 on practices (with 5 practice questions excluded from scoring as they were programmatic). Responses were validated by three medical doctors, and scoring was based on correct answers. Knowledge, attitude, and practice scores were categorized into "poor" or "good" using mean or median cutoffs depending on distribution. Logistic regression was applied to explore associations between participant characteristics and KAP outcomes.

Eligibility Criteria

Inclusion Criteria: * Companies known to produce silica dust * members of ZACCI * current active senior management role Exclusion Criteria: * none silica producing companies * junior staff

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07749872). StuddyBuddy aggregates publicly available trial information.